![]() ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. | ![]() Amoy Diagnostics Amoy Diagnostics (AmoyDx, 厦门艾德生物医药科技股份有限公司) is a company that provides molecular diagnostic products and services for oncology precision medicine. | BGI Genomics BGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services. | |
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations Xiamen, CN HQ Singapore, SG | Locations Shenzhen, CN HQ Brisbane, AU Copenhagen, DK Addis Ababa, ET Hong Kong, HK Budapest, HU Kobe, JP see more |
Employees | Employees 1,869 | Employees 1,144 | Employees 3,702 |
Valuation ($) | Valuation ($) 3.2 b | Valuation ($) 1.3 b | Valuation ($) 2.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) ¥1.2b (FY, 2025) | Revenue (est.) ¥3.7b (FY, 2025) |
Cost of goods | Cost of goods $190.5m (FY, 2025) | Cost of goods ¥208.5m (FY, 2025) | Cost of goods ¥2.3b (FY, 2025) |
Gross profit | Gross profit $269.6m (FY, 2025) | Gross profit ¥976m (FY, 2025) | Gross profit ¥1.4b (FY, 2025) |
Net income | Net income ($175.5m) (FY, 2025) | Net income ¥361.3m (FY, 2025) | Net income (¥637.8m) (FY, 2025) |

Amoy Diagnostics (AmoyDx, 厦门艾德生物医药科技股份有限公司) is a company that provides molecular diagnostic products and services for oncology precision medicine.
View companyBGI Genomics (华大基因, 深圳华大基因股份有限公司) is a company offering genomic sequencing and proteomic services.
View company